A detailed history of Cadinha & CO LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cadinha & CO LLC holds 19,390 shares of LLY stock, worth $18.1 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares
19,390
Previous 21,560 10.06%
Holding current value
$18.1 Million
Previous $12.6 Million 20.03%
% of portfolio
2.61%
Previous 2.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $1.29 Million - $1.72 Million
-2,170 Reduced 10.06%
19,390 $15.1 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $256,292 - $302,135
488 Added 2.32%
21,560 $12.6 Million
Q3 2023

Nov 01, 2023

BUY
$434.7 - $599.3 $273,861 - $377,559
630 Added 3.08%
21,072 $11.3 Million
Q2 2023

Jul 26, 2023

SELL
$350.74 - $468.98 $453,506 - $606,391
-1,293 Reduced 5.95%
20,442 $9.59 Million
Q4 2022

Jan 25, 2023

SELL
$321.55 - $374.67 $233,123 - $271,635
-725 Reduced 3.23%
21,735 $0
Q3 2022

Oct 21, 2022

SELL
$296.48 - $337.87 $320,198 - $364,899
-1,080 Reduced 4.59%
22,460 $7.26 Million
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $12.6 Million - $14.7 Million
-45,056 Reduced 65.68%
23,540 $7.63 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $474,308 - $589,444
-2,021 Reduced 2.86%
68,596 $19.6 Million
Q4 2021

Feb 03, 2022

SELL
$224.85 - $279.04 $9.14 Million - $11.3 Million
-40,652 Reduced 36.53%
70,617 $19.5 Million
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $96,839 - $119,174
-437 Reduced 0.39%
111,269 $25.7 Million
Q2 2021

Jul 29, 2021

BUY
$180.55 - $233.54 $239,589 - $309,907
1,327 Added 1.2%
111,706 $25.6 Million
Q1 2021

May 06, 2021

SELL
$164.32 - $212.72 $1.49 Million - $1.93 Million
-9,095 Reduced 7.61%
110,379 $20.6 Million
Q4 2020

Jan 22, 2021

BUY
$130.46 - $172.63 $14.5 Million - $19.2 Million
111,324 Added 1365.94%
119,474 $20.2 Million
Q1 2020

May 06, 2020

SELL
$119.05 - $147.35 $21,786 - $26,965
-183 Reduced 2.2%
8,150 $1.13 Million
Q4 2019

Jan 23, 2020

BUY
$106.92 - $132.43 $8,874 - $10,991
83 Added 1.01%
8,333 $1.1 Million
Q3 2019

Oct 30, 2019

SELL
$106.79 - $116.16 $5,339 - $5,808
-50 Reduced 0.6%
8,250 $923,000
Q2 2019

Aug 09, 2019

SELL
$110.79 - $129.32 $22,158 - $25,864
-200 Reduced 2.35%
8,300 $920,000
Q1 2019

May 08, 2019

SELL
$111.31 - $131.02 $61,220 - $72,061
-550 Reduced 6.08%
8,500 $1.1 Million
Q4 2018

Jan 29, 2019

SELL
$105.9 - $118.64 $283,812 - $317,955
-2,680 Reduced 22.85%
9,050 $1.05 Million
Q3 2018

Nov 07, 2018

SELL
$85.86 - $107.31 $15,025 - $18,779
-175 Reduced 1.47%
11,730 $1.26 Million
Q1 2018

May 10, 2018

SELL
$74.21 - $87.6 $55,360 - $65,349
-746 Reduced 5.9%
11,905 $921,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $975,012 - $1.08 Million
12,651
12,651 $1.08 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $886B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cadinha & CO LLC Portfolio

Follow Cadinha & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cadinha & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cadinha & CO LLC with notifications on news.